FDA Approves GE’s Veo Low-Dose CT Technology

The FDA has cleared GE Healthcare’s Veo computed tomography technology, which delivers clearer images at lower doses, according to a GE Healthcare news release.

Advertisement

 

Veo is the first FDA-approved CT system using the model-based iterative reconstruction technique, which is already available on GE Discovery CT750 HD systems in Europe, Canada and parts of Asia.

 

Current Veo users in Europe report successful chest CTs done with an equivalent amount of medical radiation dose as a chest x-ray, or less than one-tenth of one mSv.

 

Related Articles on Computed Tomography Systems:

GE Healthcare Launches Compact CT System After FDA Clearance

Report: CT Scanner Use Rising 6% Per Year

Study: Computed Tomography Volumetry Accurately Assesses Endocrine Function in Pancreas


 

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.